Disrupting the Senescence-Associated Secretory Phenotype-M1Macrophage Feedback Loop in Synovitis Using Dual...

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Nanotechnology

Background:

• Osteoarthritis (OA) is a major cause of disability, driven by synovitis involving senescent cells and pro-inflammatory M1 macrophages.
• Senescent cells secrete SASP, promoting M1 macrophage polarization, creating a destructive feedback loop.
• Current OA therapies targeting only senolytics or macrophages are insufficient.

Purpose of the Study:

• To develop a combinatorial nanomedicine platform to simultaneously target senescent cells and modulate macrophage phenotypes in OA.
• To disrupt the senescence-inflammation feedback loop driving OA progression.

Main Methods:

• Bioinformatics analysis integrated with clinical and murine data guided the nanomedicine design.
• A dual-component nanomedicine was created: synovium-targeting liposomes with senolytics and M2 macrophage-derived exosomes.
• The nanomedicine was tested in rat OA models.

Main Results:

• The combinatorial nanomedicine effectively cleared senescent fibroblasts and suppressed SASP.
• It successfully converted pro-inflammatory M1 macrophages to regenerative M2 phenotypes.
• Significant reductions were observed: 73.53% in synovitis index and 75.00% in OARSI scores in rat OA models.

Conclusions:

• This dual-action nanomedicine effectively disrupts the senescence-inflammation cascade in OA.
• The strategy restores joint homeostasis by concurrently clearing senescent cells and M1 macrophages.
• Presents a translatable framework for treating OA and other age-related inflammatory disorders.